News & Analysis as of

Pharmaceutical Industry › Corp Fin

Cooley LLP

Blog: Corp Fin Suggests It Will Take A Look At Non-GAAP Disclosure Practices In The Pharmaceutical Industry

Cooley LLP on

Even important industry players can sometimes run up against brick walls at Corp Fin. In a recent give-and-take with the SEC, Allergan was scolded for its use of certain non-GAAP financial measures in its press releases. ...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide